Cord-Blood Transplantation in Patients with Minimal Residual Disease
about
Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!Umbilical Cord Blood Transplantation: Challenges and Future Directions.Toward a Rapid Production of Multivirus-Specific T Cells Targeting BKV, Adenovirus, CMV, and EBV from Umbilical Cord Blood.From patient centered risk factors to comprehensive prognostic models: a suggested framework for outcome prediction in umbilical cord blood transplantation.Engineering cord blood to improve engraftment after cord blood transplant.Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMTHaploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis.Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de GrAllogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia.Immune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the ugly.Advances in umbilical cord blood cell therapy: the present and the future.Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.Alloreactivity: the Janus-face of hematopoietic stem cell transplantation.Who Should Receive a Transplant for Acute Lymphoblastic Leukaemia?Clinical Studies in Hematologic Microtransplantation.Graft predominance after double umbilical cord blood transplantation: a review.Maternal microchimerism is prevalent in cord blood in memory T cells and other cell subsets, and persists post-transplant.Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation.The Prognostic Significance of Measurable ("Minimal") Residual Disease in Acute Myeloid Leukemia.Occurrence of graft-versus-host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMT.Erythropoietin in umbilical cord blood transplantation: defining the role and implications.Going home for the holidays? Take a shortcut!Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation.Antagonism of PPAR-γ signaling expands human hematopoietic stem and progenitor cells by enhancing glycolysis.Effects of pre- and post-transplantation minimal residual disease on outcomes in pediatric patients with acute myeloid leukemia receiving human leukocyte antigen-matched or mismatched related donor allografts.Cord blood-derived T cells allow the generation of a more naïve tumor-reactive cytotoxic T-cell phenotype.Is it time to re-think a sustainable banking model for the Italian Cord Blood Network?Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission.Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study.One or two umbilical cord blood cell units? Caveat emptor.Against the odds: haplo-cord grafts protect from GvHD and relapse.Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML.Clinical T Cell Receptor Repertoire Deep Sequencing and Analysis: An Application to Monitor Immune Reconstitution Following Cord Blood Transplantation
P2860
Q30252339-B266C114-D91E-4241-AB67-E5EBF57B2BC4Q30352323-A4A799EC-8A0A-4FBF-83E8-1840D10E6289Q33633262-C66AEB0D-DF57-42BD-BA0F-57B51A6442E6Q33766984-10DE40C6-4430-4613-B2CD-9E00360DD3EBQ33766995-4F30E16B-5E70-4BAA-933A-B627018A8D41Q33820379-D17FD6B6-CCF5-4E56-9464-EC16C8B7C3F0Q33868700-0B796FCA-24F8-48C9-9822-96488FAB92C5Q36308832-A5C1E381-0A17-4A22-A177-E8C92FF05214Q38666661-FC843F45-3A2B-4155-9CE8-D1923DEFDA6EQ38685482-4FA340E9-D592-4866-8BAE-9FE8BCDE2BF9Q38728525-3D80FD5C-D292-4CB1-AC39-3952968AF749Q38734758-2138521F-E17F-41C0-926D-7EE909BCE1DDQ38747929-E14ECBA9-8979-4D1E-AD4F-6AF9050CE60BQ38922235-C3B5E640-E51A-4058-B87D-E9CCA5AA1EAFQ38953608-DC45A4B5-9850-4EC0-97CD-5F108EFFD107Q39147431-55DE5EC9-D25C-45E8-9953-78A61F70D157Q39368481-6B25C837-BB5F-4746-AFE3-33363CCB338DQ40162729-03B3D89A-FBAB-4A73-95C6-5FFCCD24DF92Q47570389-F48A69C0-55DF-4A39-A38D-5DC36E2421C2Q47804815-718694A1-9F8E-4DA9-87C5-5E8520906820Q47865655-BB9C40C3-9220-475F-B761-F0DF73859649Q47970956-D2EB08E6-443C-4B82-AF43-90B3ABA59BC6Q48324190-03E29A3F-961E-478C-B4DD-C4FE1AA6FE9FQ49391438-19881A04-4592-42BF-8FF0-C408EC20EFF1Q49612432-23F39C9E-F70A-4462-99FF-D033DB412FE7Q50000844-77C85497-7206-49F3-B22E-2FE7008A37E6Q50098673-EA41664E-078C-418C-8F7C-B3BE75130DC9Q50659098-5C697957-901D-4348-899A-D6BCA282D8A7Q50704219-946F3AF2-1DF8-4AA4-8AD4-98D38148A8F9Q52688938-E969C466-6C31-4EB9-AEF6-84304950A2E4Q52804927-8D58D0EE-1D29-4F55-B420-8D56BBAFF976Q53211922-83712689-9BC3-4FD9-AADB-8A67E835D9A1Q54718917-6F3C4402-DEB7-4430-96FF-E095E5643E64Q59129883-4CD586E9-AB01-4092-B634-9178E80EB693
P2860
Cord-Blood Transplantation in Patients with Minimal Residual Disease
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Cord-Blood Transplantation in Patients with Minimal Residual Disease
@ast
Cord-Blood Transplantation in Patients with Minimal Residual Disease
@en
type
label
Cord-Blood Transplantation in Patients with Minimal Residual Disease
@ast
Cord-Blood Transplantation in Patients with Minimal Residual Disease
@en
prefLabel
Cord-Blood Transplantation in Patients with Minimal Residual Disease
@ast
Cord-Blood Transplantation in Patients with Minimal Residual Disease
@en
P2093
P2860
P50
P356
P1476
Cord-Blood Transplantation in Patients with Minimal Residual Disease
@en
P2093
Ann Dahlberg
Ann Woolfrey
Brent Wood
Colleen Delaney
Effie Petersdorf
Filippo Milano
Joachim H Deeg
Kristine Doney
Mary E Flowers
Mohamed Sorror
P2860
P304
P356
10.1056/NEJMOA1602074
P407
P577
2016-09-01T00:00:00Z